Evidence map›Paper›PMID 40760441›Full record

ArticleImplementation science : IS2025

Maximising Embedded Pharmacists in AGed CAre Medication Advisory Committees (MEGA-MAC): protocol for implementing Australia's new guiding principles for medication management in residential aged care facilities using knowledge brokers and a national quality improvement collaborative.

Amanda J Cross, Brooke Blakeley, Kate Laver, Terry P Haines, Sarah N Hilmer, Atish Manek, Alexandra Bennett, Angelita Martini, Lyntara Quirke, Mary Ann Kulh and 8 more

Abstract read
In one paragraph

Article in Implementation science : IS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Amanda J CrossCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC, 3052, Australia. amanda.cross@monash.edu.ORCID 0000-0001-6001-9211
Brooke BlakeleyCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC, 3052, Australia.ORCID 0009-0003-1501-8828
Kate LaverCollege of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, Australia.ORCID 0000-0003-0259-2209
Terry P HainesSchool of Primary and Allied Health Care, Faculty of Medicine Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.ORCID 0000-0003-3150-6154
Sarah N HilmerKolling Institute, Northern Sydney Local Health District and The University of Sydney, Sydney, NSW, Australia.ORCID 0000-0002-5970-1501
Atish ManekDepartment of General Practice, Faculty of Medicine Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Alexandra BennettNew South Wales Therapeutic Advisory Group, Sydney, NSW, Australia.ORCID 0000-0002-9900-5316
Angelita MartiniCalvary Health Care, Sydney, NSW, Australia.ORCID 0000-0003-1886-7115
Lyntara QuirkeConsumer Representative, Australian Capital Territory, Scullin, Dementia Australia, Australia.
Mary Ann KulhSchool of Medicine and Psychology, Australian National University, Australian Capital Territory, Acton, Australia.
Sara L WhittakerRehabilitation, Ageing and Independent Living (RAIL) Research Centre, School of Primary and Allied Health Care, Monash University, Frankston, VIC, Australia.ORCID 0000-0001-7002-185X
Dayna R CeninBrightwater Research Centre, Brightwater Care Group, Inglewood, WA, Australia.ORCID 0000-0003-2598-7035
Anthony HobbsCalvary Health Care, Sydney, NSW, Australia.
Joanne MoneyGrampians Health, Ballarat, VIC, Australia.ORCID 0009-0007-3956-2173
Karina RienietsGrampians Health, Ballarat, VIC, Australia.ORCID 0009-0003-3912-2398
Kris SalisburyCalvary Health Care, Sydney, NSW, Australia.
Alene Sze Jing YongCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC, 3052, Australia.ORCID 0000-0001-6032-4582
J Simon BellCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC, 3052, Australia.ORCID 0000-0002-6115-2767

Funding

Department of Health and Aged Care, Australian Government MRFMMIP000025National Health and Medical Research Council APP2009633
6 · The paper itself

Abstract

backgroundIncomplete or delayed implementation of Guidelines can lead to potentially avoidable medication-related harm. All Australian residential aged care facilities (RACFs) are recommended to have access to a multidisciplinary medication advisory committee (MAC) to provide clinical governance of medication management. The objective of this trial is to evaluate the effectiveness and relative net benefit of using knowledge brokers, supported by a national quality improvement collaborative, to implement Australia's new Guiding Principles for Medication Management in Residential Aged Care Facilities (Guiding Principles).

methodsThe Maximising Embedded Pharmacists in AGed CAre Medication Advisory Committees (MEGA-MAC) trial will be conducted in partnership with RACFs operated by three aged care provider organizations across four states of Australia. The intervention will involve knowledge broker dyads (pharmacist plus a MAC representative [e.g. nurse]) developing, implementing and evaluating RACF-specific local action plans to implement the Guiding Principles in up to 15 RACFs. Knowledge broker dyads will be supported by a national quality improvement collaborative (MEGA-MAC collaborative) comprising clinical experts, implementation scientists and resident and caregiver representatives. An interrupted time series design will be used to assess change over time with three pre-intervention (-6, -3 and 0 months) and three post-intervention assessment time points (+ 3, + 6, + 9 months). The primary outcome will be change in pre/post RACF-level concordance with the Guiding Principles measured using quality indicators (score 0 to 28, higher scores = greater concordance). A net benefit analysis will be conducted to examine the relative costs and benefits of implementing the intervention. DISCUSSION: The MEGA-MAC trial investigates a novel multifactorial knowledge translation strategy to improve the uptake of guidelines and support safe and appropriate use of medication in RACFs. We anticipate that the findings will provide new information on the role of healthcare professionals as knowledge brokers, MACs, and quality improvement collaboratives for effective guideline implementation in RACFs. ETHICS AND DISSEMINATION: Ethics approval obtained from Monash University and Grampians Health Human Research Ethics Committees. Findings will be disseminated through professional and lay media, conference presentations and peer-reviewed publications.

trial registrationAustralian New Zealand Clinical Trial Registry (ANZCTR): ACTRN12624000894594. Registered 22nd July 2024 - Prospectively registered. https://www.anzctr.org.au/ACTRN12624000894594.aspx.

Indexed as

Advisory CommitteesHomes for the AgedMedication Therapy ManagementPharmacistsQuality ImprovementAgedAustraliaHumansImplementation ScienceClinical governanceImplementation scienceInterrupted time series analysisKnowledge translationLong-term careNet benefit analysisPractice guidelines as a topicQuality improvementQuality indicatorsQuality use of medicines

Identifiers

PMID40760441
PMCPMC12323118

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.